Earnings History Data for DBV Technologies S.A. (DBVT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

DBV Technologies S.A.

DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. DBV Technologies SA is headquartered in Bagneux, France.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
02-03-2023	AH		DBVT	DBV Technologies S.A.	255.59	-0.23	-0.23	-0.13	DBV Technologies GAAP EPS of -$1.24, revenue of $4.8M [3/2/2023 4:40 PM]	1.45	0.08 (5.84%)	1.43	0.06 (4.38%)	1.08 - 3.43	44,366	30,000	21,910
DBV Technologies GAAP EPS of -$1.24, revenue of $4.8M [3/2/2023 4:40 PM]
02-05-2022	AH		DBVT	DBV Technologies S.A.	141.05	-0.15	-0.47	-0.27	DBV Technologies GAAP EPS of -$0.30 beats by $0.10, revenue of $2.55M beats by $1.27M [5/2/2022 4:02 PM]	1.27	-0.12 (-8.30%)	1.34	-0.04 (-3.25%)	1.20 - 6.75	48,395	91,506	12,588
DBV Technologies GAAP EPS of -$0.30 beats by $0.10, revenue of $2.55M beats by $1.27M [5/2/2022 4:02 PM] DBV Technologies Reports Recent Business Developments and First Quarter 2022 Financial Results [May-02-22 04:00PM] DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq [May-02-22 05:00PM]
03-03-2022	AH	5:35 PM ET (Mar 3)	DBVT	DBV Technologies S.A.	147.20	-0.13	-0.32	0.00	DBV Technologies GAAP EPS of -$1.78 beats by $0.28, revenue of $5.70M beats by $0.83M [3/3/2022 4:27 PM]	1.34	-0.41 (-23.43%)	1.38	-0.37 (-21.14%)	1.23 - 6.88	247,295	280,000	173,706
DBV Technologies GAAP EPS of -$1.78 beats by $0.28, revenue of $5.70M beats by $0.83M [3/3/2022 4:27 PM] DBV Technologies stock slumps 21% amid FY revenue decline, plans on Peanut patch [3/4/2022 7:22 AM] DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates [Mar-03-22 04:15PM]
02-08-2021	AH	After the close (Aug 2)	DBVT	DBV Technologies S.A.	595.48	-0.28	-0.64	0.00	DBV Technologies EPS beats by $0.01 [8/2/2021 4:32 PM]	4.95	-0.42 (-7.73%)	5.14	-0.23 (-4.28%)	1.35 - 7.38	134,063	60,000	643
DBV Technologies EPS beats by $0.01 [8/2/2021 4:32 PM] DBV Technologies Reports Second Quarter 2021 Financial Results and Recent Business Developments [Aug-02-21 04:15PM]
03-05-2021	PM		DBVT	DBV Technologies S.A.	696.60	-0.27	-0.39	0.00		6.16	-0.37 (-5.67%)	6.34	-0.19 (-2.91%)	1.35 - 7.38	236,829	110,000	15,268
DBV Technologies Reports Q1 2021 Financial Results [May-03-21 01:30AM]
11-03-2021	AH	After the close (Mar 11)	DBVT	DBV Technologies S.A.	576.27	N/A	0.00	0.00	DBV Technologies EPS beats by $0.75, misses on revenue [3/11/2021 5:06 PM]	6.00	0.76 (14.50%)	5.90	0.66 (12.60%)	1.35 - 7.38	310,261	130,357	66,960
DBV Technologies EPS beats by $0.75, misses on revenue [3/11/2021 5:06 PM] DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments [Mar-11-21 04:30PM] Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2021 [Mar-12-21 04:30PM]